未登录 分享 收藏
分享 收藏
分享 收藏
Alterations in fecal microbiota composition and cytokine expression profiles in adolescents with depression: a case-control study 青少年抑郁症患者粪便菌群组成和细胞因子表达谱的变化: 一项病例对照研究 Cheng, Yiwen; Zhu, Zhangcheng; Yang, Zhi; Liu, Xia; Qian, Xiulian; Zhu, Juntao; Hu, Xinzhu; Jiang, Peijie; Cui, Tingting; Wang, Yuwei; Ding, Wenwen; Lei, Wenhui; Gao, Jie; Zhang, Jingchen; Li, Yating; Shao, Li; Ling, Zongxin; Hu, Weiming 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Xaluritamig, a STEAP1 x CD3 XmAb 2+1 immune therapy, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Initial results from dose expansion cohorts in a phase I study Xaluritamig，一种STEAP1 x CD3 XmAb 2+1免疫疗法，在转移性去势抵抗性前列腺癌（mCRPC）患者（pts）中的初步研究结果：来自一项I期研究剂量扩展队列的数据 Kelly, W. K.; Appleman, L. J.; Lin, C-C.; Armstrong, A. J.; Fischer, S. C.; Pook, D. W.; Perez Gracia, J. L.; Lee, J. L.; Berthold, D. R.; Ward, P. J.; Castellano Gauna, D. E.; Horvath, L. G.; Kim, M.; Matsubara, N.; Sumey, C.; Shabooti, M.; Yang, Z.; Connarn, J.; Stieglmaier, J.; Danila, D. C. 分享 收藏
Circulating tumour cell (CTC) enumeration and overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with xaluritamig 循环肿瘤细胞（CTC）计数和总生存期（OS）在用xaluritamig治疗的转移性去势抵抗性前列腺癌（mCRPC）男性患者中的情况 Armstrong, A. J.; Appleman, L. J.; Danila, D. C.; Lin, C-C.; Lee, J. L.; Matsubara, N.; Ward, P. J.; Pook, D. W.; Kim, M.; Dorff, T. B.; Fischer, S. C.; Lin, Y-C.; Horvath, L. G.; Sumey, C.; Yang, Z.; Decato, B. E.; Englert, J. M.; Smith, K. M.; Lolkema, M.; Kelly, W. K. 分享 收藏
Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study Qian, Siyuan; Chen, Jun; Zhao, Yongchun; Zhu, Xiuxiu; Dai, Depeng; Qin, Lei; Hong, Juan; Xu, Yanming; Yang, Zhi; Li, Yunyan; Guijo, Ismael; Jimenez-Galanes, Santos; Guadalajara, Hector; Garcia-Arranz, Mariano; Garcia-Olmo, Damian; Shen, Junjie; Villarejo-Campos, Pedro; Qian, Cheng 分享 收藏
Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) Kelly, W. K.; Danila, D. C.; Lin, C-C.; Lee, J-L.; Matsubara, N.; Ward, P. J.; Armstrong, A. J.; Pook, D. W.; Kim, M.; Dorff, T.; Fischer, S.; Lin, Y-C.; Horvath, L. G.; Sumey, C.; Yang, Z.; Jurida, G.; Connarn, J.; Penny, H.; Stieglmaier, J.; Appleman, L. J. 分享 收藏
Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC) Kelly, W.; Danila, D.; Lin, C-C.; Lee, J-L.; Matsubara, N.; Ward, P.; Armstrong, A. J.; Pook, D.; Kim, M.; Dorff, T.; Fischer, S.; Lin, Y-C.; Horvath, L. G.; Sumey, C.; Yang, Z.; Jurida, G.; Connarn, J.; Penny, H.; Stieglmaier, J.; Appleman, L. J. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Durable remission related to CAR-T persistence in R/R B-ALL and long-term persistence potential of prime CAR-T Li, Shiqi; Zhang, Jiasi; Chen, Lvzhe; Xu, Huailong; He, Liping; Liu, Lin; Zhang, Qianzhen; Yuan, Zhongtao; Shen, Junjie; Chen, Zucong; Zhang, Yingzi; Wang, Meiling; Li, Yunyan; Wang, Linling; Fang, Lihua; Chen, Yingnian; Zhu, Wei; Li, Yu; Luo, Le; Wang, Youcheng; Zhang, Dingsong; Dong, Yancheng; Yin, Ping; Zhang, Lihua; Li, Xiaoping; Hu, Xiaozhuang; Zheng, Zhongzheng; Yang, Zhi; Qian, Cheng; Wang, Sanbin 分享 收藏
Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma Zhang, Chengcheng; Wang, Linling; Zhang, Qianzhen; Shen, Junjie; Huang, Xia; Wang, Meiling; Huang, Yi; Chen, Jun; Xu, Yanmin; Zhao, Wenxu; Qi, Yanan; Li, Yunyan; Ou, Yanjiao; Yang, Zhi; Qian, Cheng 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ONCOLOGY LETTERS.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏